In this session, Angela Fitch, MD, FACP, FOMA, reviews the current landscape of GLP-1–based therapies, including approved injectable and oral options as well as agents in the development pipeline. The discussion will address mechanisms of action, efficacy and safety data, clinical indications, and practical considerations for patient selection and counseling. This talk is designed to help clinicians stay current as the role of GLP-1 therapies continues to evolve in metabolic and weight-related care.

Angela Fitch, MD, FACP, FOMA, is a board-certified obesity medicine physician and nationally recognized weight management and metabolic health expert. She is the Co-Founder and Chief Medical Officer of Knownwell, a primary care and weight management practice. Dr. Fitch is a Fellow of the Obesity Medicine Association and a leading advocate for improving access to evidence-based obesity care.

Dr. Fitch takes a comprehensive, science-backed approach to weight management, integrating medical treatments, lifestyle modifications, and behavioral strategies to help women achieve sustainable health outcomes.